David Okrongly is CEO of Autonomous Medical Devices. Dr. Okrongly has over 25 years experience in the Diagnostics industry as both a founder and senior leader at companies such as Bayer, Siemens, Quanterix, Exosome Diagnostics, OPKO Health, and LightDeck Diagnostics. His teams have brought numerous industry-leading platforms and assays to market, most recently the OPKO 4Kscore test, a blood test for aggressive prostate cancer, and the Claros 1 fingerstick whole blood POC system.
Christopher Bissell has more than 20 years of experience in corporate finance and accounting including responsibility for all aspects of the accounting function. He has held such prestigious positions as Director of Financial Planning and Control, Director of Business Planning and Divisional Controller.
His previous experience includes 8 years as a consultant to various medical device companies and 16 years with Shiseido, a multinational manufacturer and distributor of prestige consumer cosmetics. While there, he was responsible for budgeting, treasury and consolidated financial reporting. Additionally, he was responsible for coordination with all subsidiaries in North America and Brazil as well as developing strategic budgets with the sales and marketing division heads. He is currently on the board of Ballester Hermanos, one of the largest local importers and distributors of frozen and dry goods, beverages and food service in Puerto Rico.
Christopher received his undergraduate BS degree at Lehigh University in Accounting followed by an MBA in Finance at Fairleigh Dickinson University.
